UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 91

Sortiert nach

Fascin is involved in the chemotherapeutic resistance of breast cancer cells predominantly via the PI3K/Akt pathway

British journal of cancer, 2014-10, Vol.111 (8), p.1552-1561

2014

Volltextzugriff (PDF)

The safety and efficacy of durvalumab in combination with paclitaxel for the treatment of metastatic triple negative breast cancer

Annals of oncology, 2018-10, Vol.29, p.viii438-viii438

2018

Volltextzugriff (PDF)

Phase II Study of Docetaxel, Doxorubicin, and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer

Journal of clinical oncology, 2001-01, Vol.19 (2), p.314-321

2001

Volltextzugriff (PDF)

Adjuvant Docetaxel for Node-Positive Breast Cancer

The New England journal of medicine, 2005-06, Vol.352 (22), p.2302-2313

2005

Volltextzugriff (PDF)

Association Between Obesity and Clinicopathological Profile of Patients with Newly Diagnosed Non-Metastatic Breast Cancer in Saudi Arabia

International journal of women's health, 2022-01, Vol.14, p.373-384

2022

Volltextzugriff (PDF)

Association Between Neutrophil-Lymphocyte Ratio and Oncotype Dx Recurrence Score in Early-Stage Hormonal Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer

Cancer management and research, 2021-01, Vol.13, p.9411-9420

2021

Volltextzugriff (PDF)

1236TiPThe safety and efficacy of durvalumab in combination with paclitaxel for the treatment of metastatic triple negative breast cancer

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Soft tissue malignant lymphoma at sites of previous surgery

Journal of clinical pathology, 1998-08, Vol.51 (8), p.629-632

1998

Volltextzugriff (PDF)

1273P - Durvalumab and paclitaxel combination for treatment of metastatic triple negative breast cancer is safe with very promising efficacy

Annals of oncology, 2019-10, Vol.30, p.v518-v518

2019

Volltextzugriff (PDF)

1273PDurvalumab and paclitaxel combination for treatment of metastatic triple negative breast cancer is safe with very promising efficacy

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Durvalumab and paclitaxel combination for treatment of metastatic triple negative breast cancer is safe with very promising efficacy

Annals of oncology, 2019-10, Vol.30, p.v518

2019

Volltextzugriff (PDF)

264P Neutrophil-to-lymphocyte ratio as a prognostic factor for neoadjuvant chemotherapy for locally advanced breast cancer

Annals of oncology, 2020-09, Vol.31, p.S344-S344

2020

Volltextzugriff (PDF)

Prophylactic mastectomy and genetic testing: an update

Oncology nursing forum, 2000-11, Vol.27 (10), p.1537

2000

Volltextzugriff (PDF)

Docetaxel/doxorubicin/cyclophosphamide in the treatment of metastatic breast cancer

Oncology (Williston Park, N.Y.), 1997-08, Vol.11 (8 Suppl 8), p.37

1997

Volltextzugriff (PDF)

Ocular toxicity and cancer chemotherapy: A review

Cancer, 1996-10, Vol.78 (7), p.1359-1373

1996

Volltextzugriff (PDF)

Abstract P4-05-02: Role of the Atr Protein Kinase and Curcumin in Tumor-Stromal Interactions in Breast Cancer

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P4-P4-05-02

2010

Volltextzugriff (PDF)

p16 super(INK4A) Represses Breast Stromal Fibroblasts Migration/Invasion and Their VEGF-A-dependent Promotion of Angiogenesis through Akt Inhibition

Neoplasia (New York, N.Y.), 2012-12, Vol.14 (12), p.1269-1277

2012

Volltextzugriff (PDF)

Ovarian cancer gene therapy: Repeated treatment with thymidine kinase in an adenovirus vector and ganciclovir improves survival in a novel immunocompetent murine model

American journal of obstetrics and gynecology, 2000-03, Vol.182 (3), p.553-559

2000

Volltextzugriff (PDF)

Cortical Blindness as a Manifestation of Hypomagnesemia Secondary to Cisplatin Therapy: Case Report and Review of Literature

Gynecologic oncology, 1999-01, Vol.72 (1), p.120-122

1999

Volltextzugriff (PDF)

Breast cancer in the Kingdom of Saudi Arabia: A review of all female breast cancer cases from the Saudi Cancer Registry (SCR) from 1994-2004

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e12042-e12042

2010

Volltextzugriff (PDF)

Prospective phase II study of neo-adjuvant doxorubicin followed by cisplatin /docetaxel in locally advanced breast cancer—5 years of follow up

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.10574-10574

2007

Volltextzugriff (PDF)

Autologous bone marrow support and bone disease in metastatic breast cancer

Canadian journal of oncology, 1995-12, Vol.5 Suppl 1, p.33

1995

Volltextzugriff (PDF)

Autologous bone marrow support and bone disease in metastatic breast cancer

Canadian journal of oncology, 1995-07, Vol.5 (2), p.369

1995

Volltextzugriff (PDF)

Gene expression profiles of the fibroblasts from breast tumors and normal tissue compared with the tumor expression profiles

Saudi medical journal, 2006-04, Vol.27 (4), p.463

2006

Volltextzugriff (PDF)

P95 Neoadjuvant Doxorubicin followed sequentially by Cisplatin-Docetaxel in locally advanced breast cancer

Breast (Edinburgh), 2005-02, Vol.14, p.S42-S42

2005

Volltextzugriff (PDF)

1 – 25 von 91

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(82)

Publikationsform

Artikel
(90)
Berichte
(1)

Sprache

Englisch
(91)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Fascin is involved in the chemotherapeutic resistance of breast cancer cells predominantly via the PI3K/Akt pathway

The safety and efficacy of durvalumab in combination with paclitaxel for the treatment of metastatic triple negative breast cancer

Phase II Study of Docetaxel, Doxorubicin, and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer

Adjuvant Docetaxel for Node-Positive Breast Cancer

Association Between Obesity and Clinicopathological Profile of Patients with Newly Diagnosed Non-Metastatic Breast Cancer in Saudi Arabia

Association Between Neutrophil-Lymphocyte Ratio and Oncotype Dx Recurrence Score in Early-Stage Hormonal Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer

1236TiPThe safety and efficacy of durvalumab in combination with paclitaxel for the treatment of metastatic triple negative breast cancer

Soft tissue malignant lymphoma at sites of previous surgery

1273P - Durvalumab and paclitaxel combination for treatment of metastatic triple negative breast cancer is safe with very promising efficacy

1273PDurvalumab and paclitaxel combination for treatment of metastatic triple negative breast cancer is safe with very promising efficacy

Durvalumab and paclitaxel combination for treatment of metastatic triple negative breast cancer is safe with very promising efficacy

264P Neutrophil-to-lymphocyte ratio as a prognostic factor for neoadjuvant chemotherapy for locally advanced breast cancer

Prophylactic mastectomy and genetic testing: an update

Docetaxel/doxorubicin/cyclophosphamide in the treatment of metastatic breast cancer

Ocular toxicity and cancer chemotherapy: A review

Abstract P4-05-02: Role of the Atr Protein Kinase and Curcumin in Tumor-Stromal Interactions in Breast Cancer

p16 super(INK4A) Represses Breast Stromal Fibroblasts Migration/Invasion and Their VEGF-A-dependent Promotion of Angiogenesis through Akt Inhibition

Ovarian cancer gene therapy: Repeated treatment with thymidine kinase in an adenovirus vector and ganciclovir improves survival in a novel immunocompetent murine model

Cortical Blindness as a Manifestation of Hypomagnesemia Secondary to Cisplatin Therapy: Case Report and Review of Literature

Breast cancer in the Kingdom of Saudi Arabia: A review of all female breast cancer cases from the Saudi Cancer Registry (SCR) from 1994-2004

Prospective phase II study of neo-adjuvant doxorubicin followed by cisplatin /docetaxel in locally advanced breast cancer—5 years of follow up

Autologous bone marrow support and bone disease in metastatic breast cancer

Autologous bone marrow support and bone disease in metastatic breast cancer

Gene expression profiles of the fibroblasts from breast tumors and normal tissue compared with the tumor expression profiles

P95 Neoadjuvant Doxorubicin followed sequentially by Cisplatin-Docetaxel in locally advanced breast cancer

Suchergebnisse filtern